| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2008PNAS..105.7387S |
| P356 | DOI | 10.1073/PNAS.0802878105 |
| P932 | PMC publication ID | 2396702 |
| P698 | PubMed publication ID | 18492802 |
| P5875 | ResearchGate publication ID | 5357196 |
| P50 | author | Stuart Schreiber | Q906562 |
| Ralph Weissleder | Q7288259 | ||
| Mikael Pittet | Q45776556 | ||
| P2093 | author name string | Stanley Y Shaw | |
| Aravind Subramanian | |||
| Elizabeth C Westly | |||
| P2860 | cites work | Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture | Q46491954 |
| Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles. | Q48913327 | ||
| Simultaneous multicolor imaging of five different lymphatic basins using quantum dots. | Q50994936 | ||
| Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. | Q54004869 | ||
| Immunosuppressive activity, lymphocyte subset analysis, and acute toxicity of FK-506 in the rat. A comparative and combination study with cyclosporine | Q69051240 | ||
| Targeting quantum dots to surface proteins in living cells with biotin ligase | Q24527307 | ||
| Quantum dots for live cells, in vivo imaging, and diagnostics | Q24532049 | ||
| Molecular classification of cancer: class discovery and class prediction by gene expression monitoring | Q27861072 | ||
| Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats | Q29547368 | ||
| Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation | Q29547369 | ||
| GenePattern 2.0 | Q29614171 | ||
| The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions | Q29615381 | ||
| Oops they did it again! Carbon nanotubes hoax scientists in viability assays | Q29615573 | ||
| Immunological properties of engineered nanomaterials | Q29615634 | ||
| Safe handling of nanotechnology | Q29617531 | ||
| A gene expression database for the molecular pharmacology of cancer | Q29619242 | ||
| Emerging concepts in molecular MRI. | Q33264635 | ||
| Nanosize titanium dioxide stimulates reactive oxygen species in brain microglia and damages neurons in vitro | Q33305954 | ||
| Noninvasive detection of clinically occult lymph-node metastases in prostate cancer | Q34207093 | ||
| Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata | Q35251005 | ||
| Effects of the ETA/ETB receptor antagonist, bosentan on endothelin-1-induced myocardial ischaemia and oedema in the rat. | Q35873024 | ||
| Monocrystalline iron oxide nanocompounds (MION): physicochemical properties | Q36784352 | ||
| Nanotechnology safety concerns revisited | Q36865560 | ||
| In vitro toxicity evaluation of single walled carbon nanotubes on human A549 lung cells | Q40204561 | ||
| Mining and visualizing large anticancer drug discovery databases | Q40887596 | ||
| Superparamagnetic iron oxide: pharmacokinetics and toxicity | Q42146675 | ||
| Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells | Q42948890 | ||
| Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents | Q44109369 | ||
| Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro | Q44975422 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanomaterial | Q967847 |
| P304 | page(s) | 7387-7392 | |
| P577 | publication date | 2008-05-20 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Perturbational profiling of nanomaterial biologic activity | |
| P478 | volume | 105 |
| Q42128900 | 18F labeled nanoparticles for in vivo PET-CT imaging |
| Q28389697 | A 21st century paradigm for evaluating the health hazards of nanoscale materials? |
| Q38600120 | A Review of Recent Advances towards the Development of (Quantitative) Structure-Activity Relationships for Metallic Nanomaterials. |
| Q34557635 | A core-shell nanomaterial with endogenous therapeutic and diagnostic functions |
| Q51420432 | A critical appraisal of existing concepts for the grouping of nanomaterials. |
| Q35238675 | A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting |
| Q43450285 | Acute and subchronic toxicity evaluation of poly(ε-caprolactone) lipid-core nanocapsules in rats. |
| Q39702398 | Alternative Testing Strategies for Nanomaterials: State of the Science and Considerations for Risk Analysis |
| Q34537660 | Amorphous nanosilica induce endocytosis-dependent ROS generation and DNA damage in human keratinocytes. |
| Q39059539 | Association rule mining of cellular responses induced by metal and metal oxide nanoparticles |
| Q30487170 | Behavior of endogenous tumor-associated macrophages assessed in vivo using a functionalized nanoparticle. |
| Q90096114 | Big Data and Artificial Intelligence Modeling for Drug Discovery |
| Q47981832 | Biological Surface Adsorption Index of Nanomaterials: Modelling Surface Interactions of Nanomaterials with Biomolecules |
| Q39672942 | Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection |
| Q38075542 | Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials |
| Q41819990 | Cellular response of polyvalent oligonucleotide-gold nanoparticle conjugates |
| Q46722489 | Characterization of physicochemical properties of nanomaterials and their immediate environments in high-throughput screening of nanomaterial biological activity |
| Q27021154 | Chemical basis of interactions between engineered nanoparticles and biological systems |
| Q33859712 | Classification NanoSAR development for cytotoxicity of metal oxide nanoparticles |
| Q89340850 | Comparison of conventional and advanced in vitro models in the toxicity testing of nanoparticles |
| Q64231472 | Computational models for the assessment of manufactured nanomaterials: Development of model reporting standards and mapping of the model landscape |
| Q38658065 | Current Knowledge on the Use of Computational Toxicology in Hazard Assessment of Metallic Engineered Nanomaterials |
| Q30885444 | Current situation on the availability of nanostructure-biological activity data |
| Q34686914 | Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays |
| Q35564828 | Determination of the surface density of polyethylene glycol on gold nanoparticles by use of microscale thermogravimetric analysis. |
| Q39149585 | Development of structure-activity relationship for metal oxide nanoparticles |
| Q37849730 | Drug delivery from structured porous inorganic materials |
| Q60605974 | Electrochemical methods for nanotoxicity assessment |
| Q38047270 | Emerging in vitro models for safety screening of high-volume production nanomaterials under environmentally relevant exposure conditions. |
| Q28387517 | Engineered nanomaterials: exposures, hazards, and risk prevention |
| Q58690459 | Evaluation of Viability and Proliferation Profiles on Macrophages Treated with Silica Nanoparticles In Vitro via Plate-Based, Flow Cytometry, and Coulter Counter Assays |
| Q47792551 | Evaluation of antibacterial activity and toxic metal removal of chemically synthesized magnetic iron oxide titanium coated nanoparticles and application in bacterial treatment. |
| Q35203777 | Gold nanoparticles administration induced prominent inflammatory, central vein intima disruption, fatty change and Kupffer cells hyperplasia |
| Q35277095 | Gold nanoparticles induced cloudy swelling to hydropic degeneration, cytoplasmic hyaline vacuolation, polymorphism, binucleation, karyopyknosis, karyolysis, karyorrhexis and necrosis in the liver |
| Q33856349 | Heme oxygenase expression as a biomarker of exposure to amphiphilic polymer-coated CdSe/ZnS quantum dots |
| Q33621840 | Hierarchical Rank Aggregation with Applications to Nanotoxicology |
| Q35763425 | Histological alterations in the liver of rats induced by different gold nanoparticle sizes, doses and exposure duration |
| Q118383723 | How can we justify grouping of nanoforms for hazard assessment? Concepts and tools to quantify similarity |
| Q45943650 | How the toxicity of nanomaterials towards different species could be simultaneously evaluated: a novel multi-nano-read-across approach. |
| Q42953233 | Identification of gold nanoparticle-resistant mutants of Saccharomyces cerevisiae suggests a role for respiratory metabolism in mediating toxicity. |
| Q37906630 | In vivo biodistribution of nanoparticles |
| Q39663116 | Influence of size, surface area and microporosity on the in vitro cytotoxic activity of amorphous silica nanoparticles in different cell types |
| Q28397068 | Interactions of engineered nanomaterials in physiological media and implications for in vitro dosimetry |
| Q39381770 | Interference of engineered nanoparticles with in vitro toxicity assays |
| Q38974889 | Literature Review of (Q)SAR Modelling of Nanomaterial Toxicity |
| Q34321828 | Manufacture of IRDye800CW-coupled Fe3O4 nanoparticles and their applications in cell labeling and in vivo imaging |
| Q97074175 | Measuring the Stability of Supramolecular Complexes in the Proximity of Single-Walled Carbon Nanotubes |
| Q38164357 | Mechanisms of toxic action of Ag, ZnO and CuO nanoparticles to selected ecotoxicological test organisms and mammalian cells in vitro: a comparative review. |
| Q34129403 | Metal‐based nanoparticles and their toxicity assessment |
| Q37557366 | Molecular imaging in cardiovascular disease: targets and opportunities |
| Q41782452 | Molecular imaging of innate immune cell function in transplant rejection |
| Q36545276 | Multimodal iron oxide nanoparticles for hybrid biomedical imaging |
| Q39449119 | NIST gold nanoparticle reference materials do not induce oxidative DNA damage |
| Q91966152 | Nano-(Q)SAR for Cytotoxicity Prediction of Engineered Nanomaterials |
| Q44932161 | Nano-SAR development for bioactivity of nanoparticles with considerations of decision boundaries |
| Q34587815 | NanoParticle Ontology for cancer nanotechnology research |
| Q28387114 | Nanoinformatics: a new area of research in nanomedicine |
| Q28392044 | Nanomaterials toxicity and cell death modalities |
| Q37426681 | Nanomedicine for the management of lung and blood diseases |
| Q27000646 | Nanoparticle-based monitoring of cell therapy |
| Q35813733 | Nanoparticle-mediated measurement of target-drug binding in cancer cells |
| Q37341362 | Nanotechnology in medical imaging: probe design and applications. |
| Q24650444 | Nanotechnology, nanotoxicology, and neuroscience |
| Q37679570 | Nanovaccines: recent developments in vaccination |
| Q42932347 | Next-generation genome-wide association studies: time to focus on phenotype? |
| Q28383671 | No time to lose--high throughput screening to assess nanomaterial safety |
| Q53229068 | Orientation and density control of bispecific anti-HER2 antibody on functionalized carbon nanotubes for amplifying effective binding reactivity to cancer cells. |
| Q39121977 | Preclinical safety assessments of nano-sized constructs on cardiovascular system toxicity: A case for telemetry. |
| Q47337295 | Predicting Nano-Bio Interactions by Integrating Nanoparticle Libraries and Quantitative Nanostructure Activity Relationship Modeling |
| Q40955960 | Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties. |
| Q34413660 | Pro-inflammatory cytokine regulation of P-glycoprotein in the developing blood-brain barrier |
| Q41897831 | Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation |
| Q35869102 | Protective effect of the apoptosis-sensing nanoparticle AnxCLIO-Cy5.5. |
| Q39274203 | Protein corona: a new approach for nanomedicine design |
| Q94477921 | QSAR without borders |
| Q28385022 | Quantitative nanostructure-activity relationship modeling |
| Q33484683 | Rapid detection and profiling of cancer cells in fine-needle aspirates |
| Q38563725 | Recent Developments in Magnetic Diagnostic Systems |
| Q40850102 | Regulation of Multidrug Resistance P-Glycoprotein in the Developing Blood-Brain Barrier: Interplay between Glucocorticoids and Cytokines |
| Q28384365 | Relating Nanoparticle Properties to Biological Outcomes in Exposure Escalation Experiments |
| Q35277076 | Renal tissue alterations were size-dependent with smaller ones induced more effects and related with time exposure of gold nanoparticles |
| Q33798329 | Self-organizing map analysis of toxicity-related cell signaling pathways for metal and metal oxide nanoparticles |
| Q38221776 | Smart chemistry in polymeric nanomedicine. |
| Q37841416 | Standardization of models and methods used to assess nanoparticles in cardiovascular applications |
| Q28394187 | Susceptibility to quantum dot induced lung inflammation differs widely among the Collaborative Cross founder mouse strains |
| Q34121124 | TOXICITY PROFILING OF ENGINEERED NANOMATERIALS VIA MULTIVARIATE DOSE-RESPONSE SURFACE MODELING. |
| Q35218608 | The appearance of renal cells cytoplasmic degeneration and nuclear destruction might be an indication of GNPs toxicity |
| Q27013605 | The biomechanisms of metal and metal-oxide nanoparticles' interactions with cells |
| Q37720223 | The genetics of congestive heart failure |
| Q37243944 | The impact of species and cell type on the nanosafety profile of iron oxide nanoparticles in neural cells |
| Q53500294 | The status of in vitro toxicity studies in the risk assessment of nanomaterials. |
| Q33455654 | The toxicity data landscape for environmental chemicals |
| Q38875385 | Toward a systematic exploration of nano-bio interactions |
| Q37941544 | Toward toxicity testing of nanomaterials in the 21st century: a paradigm for moving forward |
| Q49912677 | Toxicity Classification of Oxide Nanomaterials: Effects of Data Gap Filling and PChem Score-based Screening Approaches. |
| Q33519917 | Unbiased discovery of in vivo imaging probes through in vitro profiling of nanoparticle libraries |
| Q37510522 | Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping. |
Search more.